🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and the Pharmaceutical Industry — Weekly 2026-W41

Weekly Aggregate2026-10-05 – 2026-10-11 · 32 items

This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.

💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
AmountDealFunctionSource
¥46 billionByteDance nurtures AI drug discovery in a separate company, raising ¥46 billion in its first funding round🧬 Drug Discovery36Kr Japan
valuation $40BIsomorphic Labs aims for $40B+ valuation in new funding, boosting AI drug discovery race.🧬 Drug DiscoveryPluang
valuation $40 billionGoogle-backed AI drug discovery firm Isomorphic Labs reportedly seeking funding at a valuation of around $40 billion🧬 Drug DiscoveryBigGo ファイナンス
valuation $40 billionAI drug discovery firm Isomorphic in talks to raise funding at a corporate valuation of over $40 billion🧬 Drug DiscoveryBloomberg.com
valuation $40 BillionIsomorphic Labs Seeks Funding at $40 Billion Valuation as AI Drug Discovery Advances🧬 Drug DiscoveryKonsulteer
$3BPhyraxis AI lands early funding as $3B pours into physical AI for drug discovery🧬 Drug DiscoveryDealroom
$1.8 BillionU.S. Government and Silicon Valley Giants Pour $1.8 Billion into Closing the AI Drug Discovery Data Gap🧬 Drug DiscoveryBigGo Finance
$1.8BMeta, Google, US Government Back $1.8B AI Biology Initiative: What It Means For Drug Discovery🧬 Drug DiscoveryHealth and Me
$1.8 billionUS government teams up with major Silicon Valley firms to invest $1.8 billion to address data shortage in AI drug discovery🧬 Drug DiscoveryBigGo ファイナンス
$1.8 BillionVirtual Biology Initiative Pools $1.8 Billion to Build Open AI Training Data for Drug Discovery🧬 Drug DiscoveryDistilled Post
up to $1 BillionNVIDIA, Eli Lilly Plan Up to $1 Billion for AI Drug Lab🏛️ Enterprise AI Platform & Governancewww.tokenpost.com
valuation $800MAI-powered drugmaker Iambic could claim $800M+ valuation in IPO🏛️ Enterprise AI Platform & GovernanceFirstWord Pharma
$382.5MKey facts: Tempus AI (TEM) Q2 $382.5M; Oncology Model for AstraZeneca🏛️ Enterprise AI Platform & GovernanceTradingView
planned $150MAI drug discovery startup Iambic seeks $150M in IPO🧬 Drug DiscoveryAxios
planned $150 millionIambic sets IPO terms, seeking $150 million to advance AI-designed cancer drugs🏛️ Enterprise AI Platform & GovernanceThe Pharma Letter
$75 millionAI biotech raises $75 million to design cancer drugs - Bizwomen🏛️ Enterprise AI Platform & GovernanceThe Business Journals
$42MRXRX Rises As Tempus AI Deal Locks In $42M🏛️ Enterprise AI Platform & Governancetimothysykes.com
€22 millionFrance's Rivercell emerges from stealth with €22 million for AI-powered drug discovery infrastructure🧬 Drug DiscoveryEU-Startups
$21 MillionTufts' Ken Getz: An AI Clinical Monitor Could Add $21 Million in Value Per Drug Program🏛️ Enterprise AI Platform & GovernanceBigGo Finance
$4MCori Clinical Raises $4M Seed Round Led By Breega For AI Clinical Trial Platform🏛️ Enterprise AI Platform & Governancehttps://ascendants.in/
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance25
← Weekly Index